Bob Lindner As co-founder and CTO, Dr. Bob Lindner oversees Veda’s scientific and engineering teams. He provides strategic vision, builds innovative technologies, and connects veda’s scientists to its Scientific Advisory Board. Bob fell hard for data science and has a passion for solving big problems. With over ten years’ experience, he is a published and …
The sum represents Sanofi’s equity investment in Owkin, plus a payment to begin a research partnership covering four types of cancer. Meanwhile, Owkin said the Sanofi investment boosts the startup…
The advancements made around telemedicine over the last 18 months are significant, but should be viewed as the first steps of an important journey for healthcare going forward.
An analysis by Evernorth found that access to outpatient mental healthcare can reduce an individual patient’s cost of care by $1,000 to $3,000 over two years.
The deadline to comply with the No Surprises – January 1 – is practically around the corner. Payers that want to be in compliance with its provider directory provision must act now.
An expert committee that advises the CDC on vaccines voted to recommend Covid-19 booster shot eligibility be thrown open to all U.S. adults.
The FDA expanded the emergency use authorization for the Pfizer and Moderna Covid-19 vaccine boosters to all adults.
The House advanced Dems’ drug pricing reforms, including cost caps for insulin and permission for Medicare to negotiate some drug prices.
Amy Abernethy, president of Verily’s clinical trials platform, laid out the pillars of the company’s strategy in 2022.
Patterns and rhythms scrambled by Covid-19 are shifting the thinking on old routines in health care and telehealth. That can be a good thing.
